Laddar...
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
NY-ESO-1 is a cancer/testis antigen expressed in a range of human malignancies, and a number of vaccine strategies targeting NY-ESO-1 are being developed. In the present study, the safety and immunogenicity of recombinant vaccinia-NY-ESO-1 and recombinant fowlpox-NY-ESO-1 were analyzed in a series o...
Sparad:
| Huvudupphovsmän: | , , , , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
National Academy of Sciences
2006
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1570182/ https://ncbi.nlm.nih.gov/pubmed/16984998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0606512103 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|